InnoPharmax Inc. (TPEX:4172)
Taiwan · Delayed Price · Currency is TWD 15.30
+0.05 (0.33%)
Mar 6, 2026, 9:40 AM CST
InnoPharmax Market Cap
InnoPharmax has a market cap or net worth of 1.65 billion as of March 5, 2026. Its market cap has decreased by -4.08% in one year.
Market Cap
1.65B
Enterprise Value
1.42B
Revenue
55.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.30
Market Cap Chart
Since September 13, 2012, InnoPharmax's market cap has increased from 1.54B to 1.65B, an increase of 6.76%. That is a compound annual growth rate of 0.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 1.65B | -8.93% |
| Dec 31, 2025 | 1.81B | 3.38% |
| Dec 31, 2024 | 1.75B | 5.76% |
| Dec 29, 2023 | 1.65B | 62.70% |
| Dec 30, 2022 | 1.02B | -32.67% |
| Dec 30, 2021 | 1.51B | 15.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Johnson Chemical Pharmaceutical Works | 2.55B |
| Golden Biotechnology | 2.30B |
| TSH Biopharm Corporation | 2.09B |
| GeneFerm Biotechnology | 1.78B |
| Tien Liang BioTech | 1.66B |
| Winston Medical Supply | 1.53B |
| DV Biomed | 1.42B |
| Excelsior Biopharma | 1.27B |